These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [Cytotoxic T-lymphocytes and the recognition of tumor antigens--an approach to "preventive tumor vaccination?"]. Peiper M; Goedegebuure PS; Eberlein TJ; Zornig C Zentralbl Chir; 1997; 122(3):141-8. PubMed ID: 9206906 [TBL] [Abstract][Full Text] [Related]
13. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating differentiated T cell localization, activation and chemokine production in established breast cancer. Dobrzanski MJ; Reome JB; Hylind JC; Rewers-Felkins KA; Abulsamad K; Adams SL Clin Immunol; 2008 Aug; 128(2):205-18. PubMed ID: 18511346 [TBL] [Abstract][Full Text] [Related]
14. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation. Ye Z; Tang C; Xu S; Zhang B; Zhang X; Moyana T; Yang J; Xiang J Cell Mol Immunol; 2007 Aug; 4(4):277-85. PubMed ID: 17764618 [TBL] [Abstract][Full Text] [Related]
15. LiveCount Assay: concomitant measurement of cytolytic activity and phenotypic characterisation of CD8(+) T-cells by flow cytometry. Devêvre E; Romero P; Mahnke YD J Immunol Methods; 2006 Apr; 311(1-2):31-46. PubMed ID: 16527300 [TBL] [Abstract][Full Text] [Related]
16. The role of T lymphocytes in the immunotherapy of tumours. Brondz BD; Balashov KE Biomed Sci; 1991; 2(5):441-9. PubMed ID: 1840832 [TBL] [Abstract][Full Text] [Related]
17. GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia. Turin I; Pedrazzoli P; Tullio C; Montini E; La Grotteria MC; Schiavo R; Perotti C; Locatelli F; Carretto E; Maccario R; Siena S; Montagna D Cytotherapy; 2007; 9(5):499-507. PubMed ID: 17786611 [TBL] [Abstract][Full Text] [Related]
18. Preclinical studies comparing different bispecific antibodies for redirecting T cell cytotoxicity to extracellular antigens on prostate carcinomas. Lum HE; Miller M; Davol PA; Grabert RC; Davis JB; Lum LG Anticancer Res; 2005; 25(1A):43-52. PubMed ID: 15816517 [TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection. Price DA; O'callaghan CA; Whelan JA; Easterbrook PJ; Phillips RE Clin Sci (Lond); 1999 Dec; 97(6):707-18. PubMed ID: 10585898 [TBL] [Abstract][Full Text] [Related]